Naglut S: A Dual Action Solution for Glycemic Control

Naglut S is a once-daily combination tablet that combines the precision of Dapagliflozin (10mg) with the effectiveness of Sitagliptin (100mg). This innovative medication offers a comprehensive approach to managing type 2 diabetes by targeting both insulin sensitivity and glucagon secretion.

How it Works: Dapagliflozin works as an SGLT2 inhibitor, promoting glucose excretion through the kidneys, while Sitagliptin inhibits dipeptidyl peptidase-4 (DPP-4), increasing levels of incretin hormones that stimulate insulin release and suppress glucagon secretion.

Benefits: Naglut S provides effective blood sugar control for adults with type 2 diabetes. Its combination therapy offers:
* Improved glycemic control: Facilitates reduced glucose levels in the bloodstream.
* Enhanced insulin sensitivity: Promotes better utilization of glucose by cells.
* Reduced cardiovascular risk: May lead to a decrease in heart failure and stroke occurrences.

Important Information: Consult your doctor for personalized advice before starting or changing any medication regimen.